Samsung Biologics, Stock Price +2.99% at This Time... 147,951 Shares Net Sold by Individuals in the Last 5 Days

As of 9:30 AM on the 12th, Samsung Biologics is trading at 828,000 KRW, up 2.99% from the previous day. The trading volume is 237,670 shares, which is 31.46% of the previous day's volume. Samsung Biologics is known as the bio business holding company of the Samsung Group.

On August 11, Jin Heung-guk, a researcher at Korea Investment & Securities, announced, "The 4th plant expansion has been decisively announced! The 4th plant will be fully operational by 2027, and the operating profit margin will exceed 50%. The facility expansion, which surpasses market expectations, provides additional upside for the stock price. This decision to expand the 4th plant has strengthened the company's long-term growth engine. We maintain a buy rating from a long-term perspective." He set the target price for Samsung Biologics at 1,000,000 KRW.

Over the past five days, individual investors have net sold 147,951 shares of Samsung Biologics, while foreigners and institutions have net bought 105,218 shares and 42,924 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.